Literature DB >> 3334575

Comparative study of two regimens in the treatment of brucellosis.

M Rodriguez Zapata1, A Gamo Herranz, J De La Morena Fernández.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3334575

Source DB:  PubMed          Journal:  Chemioterapia        ISSN: 0392-906X


× No keyword cloud information.
  5 in total

Review 1.  Recognition and optimum treatment of brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

2.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

3.  Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.

Authors:  R Lang; B Shasha; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 4.  Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.

Authors:  Julián Solís García del Pozo; Javier Solera
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

5.  Rifampicin versus streptomycin for brucellosis treatment in humans: A meta-analysis of randomized controlled trials.

Authors:  Fanjie Meng; Xiangpo Pan; Wenzhen Tong
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.